Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRTX-100 Safety and Feasibility in Rheumatoid Arthritis and Healthy Volunteers
NCT02330445Phase 2Completed
- Sponsor
- Protalex, Inc.
- Start
- Feb 2015
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of staphylococcal protein a in rheumatoid arthritis (RA), sponsored by Protalex, Inc.. Started Feb 2015; status: completed.
02
Drugs
staphylococcal protein a
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02330445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02330445.